Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros




Base de datos
Asunto de la revista
Intervalo de año de publicación
1.
J Craniofac Surg ; 27(1): 258-63, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26751427

RESUMEN

BACKGROUND: The current study was performed to elucidate changes in growth factor expression over time in critical-sized calvarial defects in rats from infancy to skeletal maturity. MATERIALS AND METHODS: Critical-sized parietal defects of 5, 6, and 8 mm were created in postnatal day 6 (P6), postnatal day (P20), and postnatal day (P84) adult rats, respectively. Dura was harvested at 3, 7, or 14 days after surgery, and serial micro-computed tomography imaging was performed through 12 weeks postoperatively. Absolute quantitative polymerase chain reaction was performed for Bone Morphogenic Protein-2 (BMP-2), Fibroblast Growth Factor-2 (FGF-2), Insulin-like Growth Factor-1 (IGF-1), and Transforming Growth Factor-ß1 (TGF-ß). RESULTS: The P6 (6-d-old) rats showed the greatest difference in gene expression between the dura derived from the defect side and the dura derived from the control side, demonstrating significant differences in TGF-ß1, BMP-2, IGF-1, and FGF-2 at various time intervals. Absolute gene expression in the defect dura was highest in the P6 rats and declined with age. Significant differences were noted at limited time points in the P20 rats for TGF-ß1 and BMP-2 as well as in the P84 rats for TGF-ß1. TGF-ß1 was the only gene studied that showed significant differences at postoperative days 3, 7, and 14 in varying age groups. CONCLUSIONS: The P6 rats have a higher osteogenic potential accompanied by a more vigorous alteration in growth factor expression compared with the P20 or P84 rats. Decrease in BMP-2 and FGF-2 as well as relative increase in TGFß-1 messenger RNA were observed in healing defects. These data provide valuable insight into the mechanism of healing of critical-sized defects and may be of use to engineer factor-releasing implants to correct skull defects.


Asunto(s)
Envejecimiento/genética , Enfermedades Óseas/fisiopatología , Péptidos y Proteínas de Señalización Intercelular/genética , Osteogénesis/genética , Hueso Parietal/fisiopatología , Animales , Enfermedades Óseas/genética , Proteína Morfogenética Ósea 2/genética , Duramadre/química , Factor 2 de Crecimiento de Fibroblastos/genética , Expresión Génica , Imagenología Tridimensional/métodos , Factor I del Crecimiento Similar a la Insulina/genética , Masculino , Hueso Parietal/química , ARN Mensajero/genética , Ratas , Tomografía Computarizada de Emisión de Fotón Único/métodos , Tomografía Computarizada por Rayos X/métodos , Factor de Crecimiento Transformador beta/genética , Factor de Crecimiento Transformador beta1/genética , Cicatrización de Heridas/genética , Microtomografía por Rayos X/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA